• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

The Case For Nations To Act On Medicines Access

23/07/2017 by William New, Intellectual Property Watch 2 Comments

NEW YORK — A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead?

Filed Under: Features, IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other, WHO

More Than Half Of People With HIV Now Have Access To Treatment, UNAIDS Says

20/07/2017 by Intellectual Property Watch Leave a Comment

For the first time, more than half of people in the world living with HIV have access to treatment, UNAIDS said in a report released today in Geneva. In addition, AIDS-related deaths have been nearly cut in half since 2005, it said. As of 2016, nearly 20 million people were living with HIV.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, United Nations - other, WHO

WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030

17/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Temporary Compulsory License For Antiretroviral Drug Upheld By German Court

17/07/2017 by Intellectual Property Watch 1 Comment

MUNICH — The German Federal Supreme Court in a decision drawing significant attention on 11 July upheld a temporary compulsory licence granted for the HIV drug Isentress (X ZB 2/17). The antiretroviral drug, based on raltegravir, has been the object of a prolonged court fight between Japanese drug company Shionogi and its US competitor Merck.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, English, Europe, Health & IP, Human Rights, IP Law, Patents/Designs/Trade Secrets, Regional Policy

Event Looks At UN High-Level Panel On Medicines Access, SDGs And Policy Coherence

15/07/2017 by Intellectual Property Watch 1 Comment

An event on 17 July at the United Nations in New York will address the “UN Secretary General’s High-Level Panel on Access to Medicines: Advancing Health-Related SDGs through Policy Coherence.”

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, United Nations - other, WHO

G20 Reaches Agreement Against Terrorism, Appears To Target Encryption

07/07/2017 by Monika Ermert for Intellectual Property Watch 2 Comments

At the G20 meeting in Hamburg today, the German hosts chose a retreat over the fight against terrorism as a warm-up, before turning to the controversial topics of free trade and climate change. Governments were very much in agreement when it comes to one thing: Internet platform providers must do more to fight radicalization and the use of the internet by terrorists.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Bilateral/Regional Negotiations, Copyright Policy, Enforcement, English, Human Rights, Other International Orgs, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

EU Parliament Adopts Marrakesh Treaty; Blind Union Prepared To Fight Publisher ‘Compensation’

06/07/2017 by Monika Ermert for Intellectual Property Watch 4 Comments

The European Parliament today with over 600 votes adopted the legal instruments to ratify the Marrakesh Treaty on access to reading material for the visually impaired. The treaty, adopted by the members of the World Intellectual Property Organization in 2013 and effective since last year, has been subject of controversies due to lobbying from publishers in the European Union, members of Parliament said today in Strasbourg before the vote. EU member states after today’s vote have one year to implement.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Development, English, Europe, Human Rights, Lobbying, Regional Policy, Technical Cooperation/ Technology Transfer, WIPO

New WHO Director Tedros’s Opening Vision: People First

04/07/2017 by William New, Intellectual Property Watch 2 Comments

Tedros Adhanom Ghebreyesus began his first week as director-general of the UN World Health Organization by addressing the WHO staff with his vision for the organisation and the world. Top of the list? Humanity.

Filed Under: IP Policies, Language, Themes, Venues, English, Featured, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

World’s Most Effective HIV Drug Rolled Out In Africa In Generic Version

29/06/2017 by Fredrick Nzwili for Intellectual Property Watch Leave a Comment

NAIROBI, Kenya – A generic version of dolutegravir (DTG), the drug of choice for the last two years for people living with HIV in high-income countries, is now available in Africa. On 28 June, the government of Kenya and drug pricing and innovation mechanism Unitaid unveiled the new first-line drug in an effort to accelerate access to better antiretroviral (ARV) drugs for her people living with HIV. It becomes the first country in Africa to introduce the generic version of drug.

Filed Under: IP Policies, Language, Themes, Venues, Africa, English, Finance, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

US High Court OKs Bigoted Trademarks

29/06/2017 by Steven Seidenberg for Intellectual Property Watch Leave a Comment

When the US Supreme Court issued its decision in Matal v. Tam, trademark applicants celebrated, hailing it as a victory for free speech and trademark rights. But some trademark owners will become very unhappy about the ramifications of the Court’s 19 June ruling.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, English, Human Rights, IP Law, North America, Perspectives on the US, Regional Policy, Trademarks/Geographical Indications/Domains

  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 156
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting